139 related articles for article (PubMed ID: 26551952)
1. Development of Uniform Protocol for Alopecia Areata Clinical Trials.
Solomon JA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):63-6. PubMed ID: 26551952
[TBL] [Abstract][Full Text] [Related]
2. Universal protocol for alopecia areata clinical studies.
Mesinkovska NA; Bergfeld WF
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S48. PubMed ID: 24326554
[TBL] [Abstract][Full Text] [Related]
3. Treatment development program: the National Alopecia Areata Foundation's initiative for achieving safe and effective therapies.
Gelula RL
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S46-7. PubMed ID: 24326553
[TBL] [Abstract][Full Text] [Related]
4. A Botanical Compound for the Treatment of Alopecia Areata and Chemotherapy-Induced Alopecia.
Patsner B; Harti S
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S69-S70. PubMed ID: 33099391
[TBL] [Abstract][Full Text] [Related]
5. Current State of Research and Summary of Preceding Summits.
Norris DA
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S1-S2. PubMed ID: 29273097
[TBL] [Abstract][Full Text] [Related]
6. Examining heterogeneity in phase II trial designs may improve success in phase III.
Tuma RS
J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
[No Abstract] [Full Text] [Related]
7. Industry Perspective on Alopecia Areata.
Wagner AT
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):67-9. PubMed ID: 26551953
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine in alopecia areata.
van den Biggelaar FJ; Smolders J; Jansen JF
Am J Clin Dermatol; 2010; 11(1):11-20. PubMed ID: 20000871
[TBL] [Abstract][Full Text] [Related]
9. Forging the Future: 2018 Alopecia Areata Research Summit Summary Report.
Ellison A; Kranz D; Mesinkovska NA; Christiano AM; Shapiro J; Norris DA
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S1-S5. PubMed ID: 33099376
[TBL] [Abstract][Full Text] [Related]
10. Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights.
Kranz D; Ellison A; Mesinkovska NA; Christiano AM; Hordinsky MK; Harris JE
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S3-S8. PubMed ID: 29273102
[TBL] [Abstract][Full Text] [Related]
11. Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review.
Almohanna HM; Ahmed AA; Griggs JW; Tosti A
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S45-S49. PubMed ID: 33099384
[TBL] [Abstract][Full Text] [Related]
12. Overview of AA and Research Progress: What Have We Learned and Where Are We Headed?
Norris DA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):6-8. PubMed ID: 26551935
[TBL] [Abstract][Full Text] [Related]
13. Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates.
Schoenmakers DH; Leferink PS; Vanderver A; Bonkowsky JL; Krägeloh-Mann I; Bernard G; Bertini E; Fatemi A; Fogel BL; Wolf NI; Skwirut D; Buck A; Holberg B; Saunier-Vivar EF; Rauner R; Dekker H; van Bokhoven P; Stellingwerff MD; Berkhof J; van der Knaap MS
BMC Neurol; 2023 Aug; 23(1):305. PubMed ID: 37592248
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
15. Investigative guidelines for alopecia areata.
Olsen EA
Dermatol Ther; 2011; 24(3):311-9. PubMed ID: 21689240
[TBL] [Abstract][Full Text] [Related]
16. An update on alopecia areata.
Kos L; Conlon J
Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
[TBL] [Abstract][Full Text] [Related]
17. A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS).
Wall D; Meah N; York K; Bhoyrul B; Bokhari L; Abraham LS; Adams R; Bergfeld W; Betz RC; Blume-Peytavi U; Callender V; Campbell C; Chambers J; Chen G; Chitreddy V; Cotsarelis G; Craiglow B; Dhurat R; Dlova N; Donovan J; Duque-Estrada B; Eisman S; Ellison A; Farrant P; Barberá JF; Gadzhigoroeva A; Grimalt R; Harries M; Hordinsky M; Irvine AD; Jolliffe V; Jones L; King B; Lee WS; Lortkipanidze N; McMichael A; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Riley M; Rudnicka L; Saceda Corralo D; Shapiro J; Sharma P; Silyuk T; Kaiumov S; Tobin DJ; Tosti A; Vañó-Galván S; Vogt A; Wade M; Yip L; Zlotogorski A; Zhou C; Sinclair R
JAMA Dermatol; 2021 Apr; 157(4):1-11. PubMed ID: 33656556
[TBL] [Abstract][Full Text] [Related]
18. Therapy of alopecia areata: on the cusp and in the future.
Price VH
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Trink A; Sorbellini E; Bezzola P; Rodella L; Rezzani R; Ramot Y; Rinaldi F
Br J Dermatol; 2013 Sep; 169(3):690-4. PubMed ID: 23607773
[TBL] [Abstract][Full Text] [Related]
20. Excimer laser: a module of the alopecia areata common protocol.
McMichael AJ
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S77-9. PubMed ID: 24326569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
